Using NF-κB as a molecular target for theranostics in radiation oncology research. [electronic resource]
Producer: 20120611Description: 139-46 p. digitalISSN:- 1744-8352
- Animals
- Antineoplastic Agents -- pharmacology
- Benzenesulfonates -- pharmacology
- Combined Modality Therapy
- Drug Resistance, Neoplasm
- Humans
- Molecular Targeted Therapy
- NF-kappa B -- antagonists & inhibitors
- Neoplasms -- diagnosis
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Prognosis
- Pyridines -- pharmacology
- Radiation Oncology
- Radiation Tolerance -- drug effects
- Signal Transduction
- Sorafenib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.